McCarthy Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-80
Closed -$3K 84
2022
Q1
$3K Hold
80
﹤0.01% 238
2021
Q4
$2K Buy
80
+40
+100% +$1.04K ﹤0.01% 274
2021
Q3
$1K Hold
40
﹤0.01% 316
2021
Q2
$2K Sell
40
-40
-50% -$1.43K ﹤0.01% 325
2021
Q1
$2K Sell
80
-30
-27% -$1.02K ﹤0.01% 286
2020
Q4
$3K Buy
+110
New +$2.25K ﹤0.01% 225

Other funds holding CLB

McCarthy Asset Management's CLB Position: Q2 2022 in Review

McCarthy Asset Management sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 80 shares — an estimated $3K sold.

McCarthy Asset Management first reported a position in CLB in Q4 2020 and held it in 6 quarters. The position peaked at $3K in Q1 2022. 176 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

  • McCarthy Asset Management reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
  • McCarthy Asset Management sold 80 Core Laboratories shares in Q2 2022, an estimated $3K.
  • McCarthy Asset Management first reported a position in Core Laboratories in Q4 2020 and held it in 6 quarters.
  • McCarthy Asset Management's Core Laboratories position peaked at $3K in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.